Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | REGN7075 |
Synonyms | |
Therapy Description |
REGN7075 is a bispecific antibody targeting EGFR and CD28, which may trigger cytotoxic T-lymphocytes-mediated immune response against EGFR-expressing tumor cells (NCI Thesaurus). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
REGN7075 | REGN-7075|REGN 7075 | EGFR Antibody 56 | REGN7075 is a bispecific antibody targeting EGFR and CD28, which may trigger cytotoxic T-lymphocytes-mediated immune response against EGFR-expressing tumor cells (NCI Thesaurus). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|